Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Irbesartan, sold under the brand name Aprovel among others, is a medication used to treat hypertension (high blood pressure), heart failure, and diabetic kidney disease. It is a reasonable initial treatment for high blood pressure. It is taken by mouth. Versions are available as the combination irbesartan/hydrochlorothiazide.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Irbesartan.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Irbesartan shows recurring relationship patterns in the source. For example, Irbesartan → Aprovel, Avapro, Bristol-Myers Squibb, In, It, Karvea, Sanofi Research, Sanofi-Aventis, United States Another extracted example is Irbesartan → Drug Administration, FDA, Health Canada, II, In, September, The FDA, US Food. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
blood pressure kidney effects combination aprovel hypertension medication available high nitrosamine side hydrochlorothiazide name others mouth may also impurities brand
TTTA extracted 52 structured relationships around Irbesartan. Examples in this analysis include Irbesartan → 3D model (JSmol) → Interactive image and Irbesartan → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Irbesartan | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Irbesartan | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Irbesartan | ATC code | C09CA04 (WHO) C09DA04 (WHO) | 1.00 | infobox |
| Irbesartan | Bioavailability | 60% to 80% | 1.00 | infobox |
| Irbesartan | CAS Number | 138402-11-6 Y | 1.00 | infobox |
| Irbesartan | ChEBI | CHEBI:5959 Y | 1.00 | infobox |
| Irbesartan | ChEMBL | ChEMBL1513 Y | 1.00 | infobox |
| Irbesartan | ChemSpider | 3618 Y | 1.00 | infobox |
| Irbesartan | CompTox Dashboard (EPA) | DTXSID0023169 | 1.00 | infobox |
| Irbesartan | Drug class | Cardiovascular agent | 1.00 | infobox |
| Irbesartan | DrugBank | DB01029 Y | 1.00 | infobox |
| Irbesartan | ECHA InfoCard | 100.119.966 | 1.00 | infobox |
| Irbesartan | Elimination half-life | 11 h to 15 h | 1.00 | infobox |
| Irbesartan | Excretion | Kidney 20%, feces 65% | 1.00 | infobox |
| Irbesartan | Formula | C25H28N6O | 1.00 | infobox |
| Irbesartan | IUPHAR/BPS | 589 | 1.00 | infobox |
| Irbesartan | KEGG | D00523 Y | 1.00 | infobox |
| Irbesartan | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Irbesartan | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Irbesartan | Legal status | US: ℞-only | 1.00 | infobox |
| Irbesartan | Legal status | EU: Rx-only | 1.00 | infobox |
| Irbesartan | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Irbesartan | License data | US DailyMed: Irbesartan | 1.00 | infobox |
| Irbesartan | MedlinePlus | a698009 | 1.00 | infobox |
| Irbesartan | Metabolism | Liver (CYP2C9) | 1.00 | infobox |
| Irbesartan | Molar mass | 428.540 g·mol−1 | 1.00 | infobox |
| Irbesartan | Pregnancy category | AU: D | 1.00 | infobox |
| Irbesartan | Pronunciation | /ɜːrbəˈsɑːrtən/ | 1.00 | infobox |
| Irbesartan | Protein binding | ~90% | 1.00 | infobox |
| Irbesartan | PubChem CID | 3749 | 1.00 | infobox |
The concept neighborhoods around Irbesartan bring nearby vocabulary together. In this analysis, examples include Combination, Administration and Angiotensin. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Irbesartan, one of the stronger structural bridges in this analysis connects Irbesartan with Side effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Irbesartan to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Irbesartan · EN edition · Analysis: TopicsToTalkAbout